Piensa AEH

Skip to main content

This website is intended for users outside of the US and UK.

User account menu

Log in

what is HAE?

Get to know the symptoms of HAE, like random swelling and pain¹

living with HAE

Get to know how HAE may affect you and your family— and how to manage it

I'm a healthcare provider

identifying HAE

Get to know the signs of HAE, a rare disease that’s often misdiagnosed²

managing HAE

Get to know the emotional impact of HAE and more

Login Form

Email Address

Password

If you are currently registered with Takeda ID Colombia, you can use your account to log in. By clicking the Enter button, you confirm that you accept the terms and conditions and the privacy and data handling policy of the site

Create new account
Reset your password

This website is intended for users outside of the US and UK.

References: 1. Longhurst HJ, Bork K. Hereditary angioedema: causes, manifestations and treatment. Br J Hosp Med (Lond). 2006;67(12):654-657. 2. Banerji A, Busse P, Christiansen SC, et al. Current state of hereditary angioedema management: a patient survey. Allergy Asthma Proc. 2015;36:213-217.

Footer menu

Site Map
Privacy & Cookies Policy
Legal Notice
Contact Us

This website is intended for users outside of the US and UK. The website has been developed by Takeda in accordance with industry and legal standards. Takeda makes every reasonable effort to include accurate and current information. However, the information provided on the website is not exhaustive and should not be used in place of a visit, call, consultation, or advice of your doctor or other healthcare professional. Takeda does not recommend the self-management of health problems. Should you have any healthcare-related questions, please call or see your doctor or other healthcare professional promptly. You should never disregard medical advice or delay in seeking it because of something you have read here.

Copyright © 2021 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda Logo are trademarks of Takeda Pharmaceutical Company Limited. C-ANPROM/INT//5160 March 2021

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Find out more